Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 29, 2019 09:00 ET | Source: Generex Biotechnology Corp.

Upmarket Deal at $2.50 Per Share Saves Generex Biotechnology Shareholders $14+ Million

Generex and Veneto Holdings Re-Negotiate Acquisition from a $35 Million Total Consideration to a $21 Million Stock-Only Transaction at $2.50 Per Share to Satisfy Generex’ Obligations MIRAMAR, FL,...